advertisement
Editors Selection IGR 21-3
List of Editor's Selection comments by
Fotis Topouzis
Chair, I Department of Ophthalmology, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
Surgical Treatment: Drainage Devices III (21-3, March 2021) on:
90583 A European Study of the Performance and Safety of MINIject in Patients With Medically Uncontrolled Open-angle Glaucoma (STAR-II)
García Feijoó J; Denis P; Hirneiß C et al.
Journal of Glaucoma 2020; 29: 864-871
Medical Treatment: The Importance of Being Adherent (21-1, November 2020) on:
84925 The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study
Newman-Casey PA; Niziol LM; Gillespie BW et al.
Ophthalmology 2020; 127: 477-483
Medical Treatment: Regulating Outflow Resistance post-Schlemm (19-3, December 2018) on:
76886 Pharmacological regulation of outflow resistance distal to Schlemm's canal
McDonnell F; Dismuke WM; Overby DR et al.
American Journal of Physiology and Cell Physiology 2018; 315: C44-C51
Medical Treatment: Investigational new drugs (17-4, September 2016) on:
67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Myers JS; Sall KN; DuBiner H et al.
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562
Medical Treatment: Combination Therapy Switch (17-1, January 2016) on:
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M; Adachi M; Hamada N et al.
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
Glaucoma Screening and Detection: Recommendation Statement (15-3, May 2014) on:
54878 Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement
Moyer VA
Annals of Internal Medicine 2013; 159: 484-489
Health Economics: Resource use in POAG (14-3, April 2013) on:
50964 Longitudinal trends in resource use in an incident cohort of open-angle glaucoma patients: resource use in open-angle glaucoma
Stein JD; Niziol LM; Musch DC et al.
American Journal of Ophthalmology 2012; 154: 452-459.e2
Glaucoma and Systemic Disease: Statin use, hyperlipid emia and glaucoma (14-2, February 2013) on:
50575 The Relationship Between Statin Use and Open-Angle Glaucoma
Stein JD; Newman-Casey PA; Talwar N et al.
Ophthalmology 2012; 119: 2074-2081
Basic Research: Diurnal IOP patterns (12-3, December 2010) on:
26328 Diurnal Intraocular Pressure Patterns are Not Repeatable in the Short Term in Healthy Individuals
Realini T; Weinreb RN; Wisniewski SR
Ophthalmology 2010; 117: 1700-1704
Bloodflow: Ocular perfusion pressure and OAG (12-3, December 2010) on:
26794 Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: the singapore malay eye study
Zheng Y; Wong TY; Mitchell P et al.
Investigative Ophthalmology and Visual Science 2010; 51: 3399-3404
Medical Treatment: Dry eye and glaucoma (treatment) (12-1, June 2010) on:
25462 Characteristics of respondents with glaucoma and dry eye in a national panel survey
Schmier J K; Covert D W
Clinical Ophthalmology 2009; 3: 645-650
Medical Treatment: Doctor-patient communication and adherence (11-4, March 2010) on:
25001 Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice
Friedman DS; Hahn SR; Quigley HA et al.
Ophthalmology 2009; 116: 2277-2285
Comments (10-3, December 2008) on:
21848 The additional yield of a periodic screening programme for open-angle glaucoma: A population-based comparison of incident glaucoma cases detected in regular ophthalmic care with cases detected during screening
Stoutenbeek R; de Voogd S; Wolfs RC et al.
British Journal of Ophthalmology 2008; 92: 1222-1226
Surgical Treatment: CEC in one- versus two-site phacotrab (10-3, December 2008) on:
21602 A comparison of corneal endothelial cell changes after 1-site and 2-site phacotrabeculectomy
Nassiri N; Rahnavardi M et al.
Cornea 2008; 27: 889-894
Health economics: Cost of screening (10-2, September 2008) on:
20983 Screening for open angle glaucoma: Systematic review of cost-effectiveness studies
Hernández R; Rabindranath K; Fraser C et al.
Journal of Glaucoma 2008; 17: 159-168
General aspects: Fear of blindness (9-4, March 2008) on:
19996 Fear of blindness in the Collaborative Initial Glaucoma Treatment Study patterns and correlates over time
Janz NK; Wren PA; Guire KE et al.
Ophthalmology 2007; 114: 2213-2220
Comments (9-4, March 2008) on:
20036 Predictors of long-term progression in the Early Manifest Glaucoma Trial
Leske MC; Heijl A; Hyman L et al.
Ophthalmology 2007; 114: 1965-1972
Screening and Prevention: Relatives of OAG patients in the USA (9-3, December 2007) on:
19568 Targeting relatives of patients with primary open angle glaucoma: The Help the Family Glaucoma Project
Okeke CN; Friedman DS; Jampel HD et al.
Journal of Glaucoma 2007; 16: 549-555
